Navigation Links
VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
Date:9/24/2008

se 2 clinical trial, the FDG-PET Trial. Enrollment in this trial is ongoing and endpoints in this study include reduction in carotid plaque inflammation following dosing with VIA-2291 as measured with state-of-the-art FDG-PET imaging technology, as well as assessment of standard biomarker measurements of inflammation.

About VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc. is a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease. VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need: reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke. The company's lead drug candidate, VIA-2291, is in multiple Phase 2 clinical studies in patients with cardiovascular disease. For more information, visit: http://www.viapharmaceuticals.com.

Forward-Looking Statements

This press release may contain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or to VIA's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause VIA's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  Conkwest, Inc., the Natural Killer ... Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as ... Soon-Shiong , NantWorks founder, physician scientist and biotechnology ... purchase approximately $48 million of the Company,s Class ... he will be named Co-Chairman of the Conkwest ...
(Date:12/24/2014)... and LONDON , December 24, 2014 ... are expected to grow at an average rate of ... value and volume. Hip, knee and spine surgeries are ... in emerging economies they have a lower penetration. Increased ... the use of composites. Non-metallic orthopedic devices have gained ...
(Date:12/24/2014)... , Dec. 23, 2014  Advanced Medical ... company engaged primarily in the development of brachytherapy ... applications, today announced that it has filed a ... and Drug Administration ("FDA") for marketing clearance for ... 513(f)(2) of the U.S. Food, Drug and Cosmetic ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... Obama administration embarks on improving the efficiency of government ... Medicare & Medicaid Services, (CMS) supervision of the Medicare ... pressed to find a government operation more outdated, mismanaged ... fact, recent audits by the government,s own contractors demonstrate ...
... Pa., Feb. 10, 2011 Kensey Nash Corporation (Nasdaq: ... the Canaccord Genuity Musculoskeletal Conference held on Tuesday, February ... Douglas G. Evans, Kensey Nash,s Chief Operating ... 3:00 p.m. (PT).  The presentation materials will be available ...
Cached Medicine Technology:Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 2Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 3Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 4Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 5
(Date:12/24/2014)... Dec. 24, 2014 (HealthDay News) -- Adults who ... risk of migraine headaches, suggests a study published ... . "Childhood maltreatment can have long-lasting effects, ... in adulthood," study author Dawn Buse, director of ... York City, said in a journal news release. ...
(Date:12/24/2014)... lab technician with the U.S. Centers for Disease Control ... virus in an agency laboratory in Atlanta earlier this ... workers are being checked for possible exposure, CDC officials ... Monday when CDC scientists doing research on Ebola mistakenly ... another CDC lab in the same building, the ...
(Date:12/24/2014)... 2014 For chic ladies, new fashionable outfits ... part of their Holiday Wish List, Angeldress.co.uk has ... ways to accent ladies’ holiday wardrobe by launching a promotion ... all over the discount of 80% off, like a cheap ... ship. The company’s chic wedding dresses are among the hottest ...
(Date:12/24/2014)... Dallas, Texas (PRWEB) December 24, 2014 ... COC Industry is a professional and in-depth research ... the report introduces COC basic information, including its ... policy analysis, news analysis, etc. This report also ... structure etc. Production is separated by regions, technology ...
(Date:12/24/2014)... Marietta, GA (PRWEB) December 24, 2014 Verde ... more comical than ever. "Last years homemade Christmas sweater ... even uglier. The 2014 winner is Tandy Wilson for ... creative ugly sweater enthusiast," says Kirk Kimmerling DDS. "She took ... to angels on the sweater." , "Every year ...
Breaking Medicine News(10 mins):Health News:Abuse in Childhood Tied to Migraines in Adulthood 2Health News:CDC Monitors Lab Worker for Possible Ebola Exposure 2Health News:Angeldress.co.uk Starts Its Big Sales by Offering Various Kinds of Cheap Clothes and Fashion Accessories 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2
... Distinctively Blue Award for Hospital Quality,Improvement, ... hospital-acquired infections in the mid-Atlantic region were,recently ... BlueCross BlueShield,Association of America. CareFirst BlueCross BlueShield ... Innovations for the 100,000 Lives and,Beyond Collaborative. ...
... Florida,s hospitals and the,Coalition to Protect Florida,s ... today to restore no-fault auto insurance, calling it ... in auto,accidents. Governor Crist,s signing into law ... and mandatory Personal Injury Protection (PIP),coverage, will be ...
... investigating claims that pain pumps used in the shoulder ... joint may cause life-long pain and suffering, ... surgeon this week issued a warning that a,commonly used device ... in the shoulder joint space. The devices, manufactured,by Stryker Corporation ...
... say , THURSDAY, Oct. 11 (HealthDay News) -- A ... be linked to a pathway that clears cholesterol from ... , They said their finding could help lead ... of cholesterol-related diseases such as atherosclerosis (clogged arteries) and ...
... 11 Collaborative Drug Discovery,Inc. (CDD, Inc.) and ... a project aimed at speeding the development of ... The collaboration combines the malaria drug data and ... of the St. Jude,Department of Chemical Biology and ...
... Properties, Inc. (NYSE: NHP ) announced today that ... November 6, 2007 after the,close of trading on the ... call on Wednesday, November 7, 2007 at 8:30 a.m. ... the Company,s financial,performance and operating results for the third ...
Cached Medicine News:Health News:National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts 2Health News:Hospital Coalition Says Governor's No-Fault Bill Signing Provides a 'Great Protection' for Florida Consumers 2Health News:Study Author Urges Peers to Stop Using Pain Pumps in the Shoulder Joint as Seasonal Surge in Use Approaches 2Health News:Study Author Urges Peers to Stop Using Pain Pumps in the Shoulder Joint as Seasonal Surge in Use Approaches 3Health News:Long-Life Gene Might Help Lower Cholesterol 2Health News:Collaborative Drug Discovery, Inc. and St. Jude Children's Research Hospital Make Malaria Research Data Available to Speed Drug Development 2Health News:Collaborative Drug Discovery, Inc. and St. Jude Children's Research Hospital Make Malaria Research Data Available to Speed Drug Development 3Health News:NHP Announces Third Quarter Earnings Release Date and Conference Call/Webcast 2Health News:NHP Announces Third Quarter Earnings Release Date and Conference Call/Webcast 3
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With tubular base • not ...
... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
... concave seats and large backrests with ... seats, backrests, armrests, and casters and ... for top performance in a variety ... clean room, static control, health care ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With Tubular Base....
Medicine Products: